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Epilepsy is characterized by periods of excessive neuro-
nal activity called seizures. While much is known about
population behaviors of neurons during seizures, as
measured by EEG electrodes, very little is known about
t h ea c t i v i t ya tt h ec e l l u l a rl e v e l .T h ee t i o l o g yo ft h ed i s -
ease can often be traced to specific mutations in parti-
cular ion channels [1]. These same ion channels are
often the targets of antiepileptic drugs. Bridging the
molecular scale causes and treatment of epilepsy to the
network scale phenotype is a multi-scale problem that
needs to be solved in order to develop more rational
approaches to treating epilepsy.
Our research seeks to understand the basic mechan-
isms of epilepsy by understanding how network syn-
chrony is affected by molecular level changes caused by
epileptogenic mutations and antiepileptic drugs. Our
approach is guided by experimental evidence, in a rat
model of epilepsy, indicating that synchrony in the net-
work changes over the different phases of the seizure
[2]. Changes in synchrony m a yh o l dak e yt ou n d e r -
standing the causes and developing novel treatments for
epilepsy. However, why synchrony changes during a sei-
zure is still a mystery.
To better understand how neurons synchronize, we
use pulse coupled oscillator theory [3]. The dynamics of
the neuron are reduced to a simple input-output rela-
tionship, measuring how synaptic inputs applied at dif-
ferent phases of a periodically firing neuron advances or
delays the spike, resulting in a Phase-Response Curve
(PRC). From the measured PRC, it is possible to predict
how a network of neurons will synchronize [4,5]. We
then measure how epileptogenic mutations and antiepi-
leptic drugs affect the neuron’sP R Ct oi n f e rh o wi t
changes the synchronizability of the network. By
measuring the effects of these changes at the molecular
level we know causes epilepsy, we can bridge the effect
to a population.
Computational simulations and in vitro experiments
measuring PRCs from neurons will be presented. We
find that epileptogenic mutations in voltage gated
sodium channels and potassium channels affect the neu-
rons’ PRCs to increase network synchrony while antiepi-
leptic drugs decrease synchrony. We hypothesize that
w h i l em a n ya n t i e p i l e p t i cd r u g sh a v ev e r yd i f f e r e n t
mechanisms of action, their common feature may be
that they decrease network synchrony.
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